Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Get More Reg Science Funds In Emergency Countermeasures Initiative

This article was originally published in The Gray Sheet

Executive Summary

FDA's initiative to improve regulatory science is slated to receive $170 million in funding as part of a government-wide effort to overhaul the system for developing and producing medical countermeasures to address public health emergencies

You may also be interested in...



Sebelius HHS Tenure Dominated By ACA Coverage, But Also Focused On Fraud, Transparency

HHS Secretary Kathleen Sebelius is resigning, and Office of Management and Budget Director Sylvia Mathews Burwell has been nominated to take over her cabinet post, President Obama announced April 11.

Venture HHS: Planned Gov't Fund For Emergency Products Elicits VC Caution

The Obama administration plans to ask Congress to authorize an independent strategic investment fund to provide financial support for small companies developing medical products that can be used to respond to bioterror attacks, pandemic flu outbreaks or other public health emergencies

Venture HHS: Planned Gov't Fund For Emergency Products Elicits VC Caution

The Obama administration plans to ask Congress to authorize an independent strategic investment fund to provide financial support for small companies developing medical products that can be used to respond to bioterror attacks, pandemic flu outbreaks or other public health emergencies

Related Content

Topics

UsernamePublicRestriction

Register

MT029276

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel